PALATIN TECHNOLOGIES, INC. Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31)
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PALATIN TECHNOLOGIES, INC. development stage entities, stock issued, value, issued for cash (deprecated 2015-01-31) for fiscal 2013 was $17.44M.
- PALATIN TECHNOLOGIES, INC. development stage entities, stock issued, value, issued for cash (deprecated 2015-01-31) for fiscal 2011 was $15.92M, a 128.69% increase from fiscal 2010.
- PALATIN TECHNOLOGIES, INC. development stage entities, stock issued, value, issued for cash (deprecated 2015-01-31) for fiscal 2010 was $6.96M.
| Period end | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) 3 month | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) 12 month |
|---|---|---|
| 2013-06-30 | $17.44M 10-K · filed 2014-09-12 | |
| 2011-06-30 | $15.92M 10-K · filed 2013-09-27 | |
| 2010-06-30 | $6.96M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |